Zavedos Cs

Zavedos CS is an intravenous chemotherapy medication containing idarubicin hydrochloride. It is used in cancer treatment to slow or stop the growth of certain cancer cells. This product is manufactured by Laboratórios Pfizer Lda. and sourced from the EU.

Idarubicin hydrochloride, the active ingredient in Zavedos CS, is primarily used in chemotherapy regimens for certain types of cancer. It may be prescribed for conditions such as acute myeloid leukemia or other malignancies where anthracycline therapy is indicated. Patients often ask, 'what is idarubicin used for' to understand its role in treatment plans.

As a chemotherapy agent, idarubicin works by interfering with the growth of cancer cells. It is designed to target rapidly dividing cells, which is a common characteristic of cancerous tissues. Users may experience effects such as hair thinning or changes in blood cell counts during treatment.

Zavedos CS is administered under medical supervision due to its potent nature. Patients should inform their healthcare provider about all medications and conditions before starting treatment. Proper handling and disposal of this medication are essential to prevent accidental exposure.

Idarubicin may interact with other medications, including certain antibiotics, blood thinners, or drugs that affect the heart. Alcohol and herbal supplements should be discussed with a healthcare provider. CYP450 enzyme inhibitors or inducers may also alter its effects.